AFP
CVS icon

Ausdal Financial Partners’s CVS Health CVS Stock Holding History

Ausdal Financial Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$441K Sell
6,144
-431
-7% -$33.2K 0.02% 630
2025
Q4 		$522K Buy
6,575
+727
+12% +$57.3K 0.02% 536
2025
Q3 		$441K Buy
5,848
+1,550
+36% +$106K 0.02% 597
2025
Q2 		$296K Sell
4,298
-1,132
-21% -$74.2K 0.02% 560
2025
Q1 		$368K Buy
+5,430
New +$325K 0.03% 455
2024
Q2 		– Sell
-4,866
Closed -$388K – 504
2024
Q1 		$388K Buy
4,866
+15
+0.3% +$1.15K 0.05% 320
2023
Q4 		$383K Buy
4,851
+749
+18% +$53.3K 0.05% 301
2023
Q3 		$286K Buy
4,102
+41
+1% +$2.9K 0.04% 347
2023
Q2 		$281K Buy
4,061
+68
+2% +$4.84K 0.04% 339
2023
Q1 		$297K Sell
3,993
-269
-6% -$22.6K 0.04% 353
2022
Q4 		$397K Sell
4,262
-253
-6% -$24.4K 0.06% 277
2022
Q3 		$431K Buy
4,515
+94
+2% +$9.3K 0.07% 267
2022
Q2 		$410K Sell
4,421
-2,674
-38% -$261K 0.06% 288
2022
Q1 		$718K Buy
7,095
+425
+6% +$44.6K 0.1% 217
2021
Q4 		$688K Sell
6,670
-53
-0.8% -$4.9K 0.09% 229
2021
Q3 		$571K Sell
6,723
-58
-0.9% -$4.86K 0.08% 251
2021
Q2 		$566K Sell
6,781
-299
-4% -$24.5K 0.09% 240
2021
Q1 		$533K Buy
7,080
+880
+14% +$64.1K 0.09% 237
2020
Q4 		$423K Buy
6,200
+143
+2% +$9.3K 0.08% 252
2020
Q3 		$354K Sell
6,057
-3,225
-35% -$201K 0.09% 229
2020
Q2 		$603K Sell
9,282
-55
-0.6% -$3.46K 0.2% 125
2020
Q1 		$582K Buy
9,337
+1,134
+14% +$75.7K 0.21% 121
2019
Q4 		$579K Buy
8,203
+3,637
+80% +$255K 0.17% 152
2019
Q3 		$288K Buy
4,566
+134
+3% +$7.94K 0.1% 234
2019
Q2 		$251K Buy
4,432
+86
+2% +$4.63K 0.1% 241
2019
Q1 		$234K Buy
4,346
+76
+2% +$4.69K 0.1% 230
2018
Q4 		$280K Sell
4,270
-213
-5% -$15.9K 0.14% 181
2018
Q3 		$353K Sell
4,483
-189
-4% -$13.5K 0.1% 247
2018
Q2 		$301K Sell
4,672
-28
-0.6% -$1.84K 0.09% 275
2018
Q1 		$292K Buy
4,700
+293
+7% +$21K 0.1% 253
2017
Q4 		$320K Buy
4,407
+823
+23% +$59.8K 0.11% 237
2017
Q3 		$291K Sell
3,584
-102
-3% -$8.07K 0.12% 231
2017
Q2 		$297K Buy
3,686
+39
+1% +$3.08K 0.13% 216
2017
Q1 		$286K Buy
3,647
+456
+14% +$36.4K 0.13% 202
2016
Q4 		$252K Buy
3,191
+229
+8% +$18.5K 0.12% 199
2016
Q3 		$264K Buy
2,962
+7
+0.2% +$661 0.13% 186
2016
Q2 		$283K Buy
+2,955
New +$294K 0.15% 172
2016
Q1 		– Sell
-2,195
Closed -$215K – 368
2015
Q4 		$215K Buy
+2,195
New +$215K 0.11% 197

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ausdal Financial Partners's CVS Position: Q1 2026 in Review

Ausdal Financial Partners reduced its CVS Health (CVS) stake by 6.6% in Q1 2026, selling an estimated $33.2K and leaving 6,144 shares worth $441K. The position accounts for 0.02% of the portfolio, ranked #630.

Ausdal Financial Partners first reported a position in CVS in Q4 2015 and has held it in 38 quarters since. The position peaked at $718K in Q1 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Ausdal Financial Partners held 6,144 shares of CVS Health worth $441K as of Q1 2026.
  • Ausdal Financial Partners sold 431 CVS Health shares in Q1 2026, an estimated $33.2K.
  • CVS Health made up 0.02% of Ausdal Financial Partners's portfolio in Q1 2026, its #630 holding.
  • Ausdal Financial Partners first reported a position in CVS Health in Q4 2015 and has held it in 38 quarters since.
  • Ausdal Financial Partners's CVS Health position peaked at $718K in Q1 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Ausdal Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.